|
1
|
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.
|
Nature
|
2007
|
2.78
|
|
2
|
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.
|
Cancer Cell
|
2013
|
2.28
|
|
3
|
hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl.
|
Curr Biol
|
2003
|
1.52
|
|
4
|
A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen.
|
Gastroenterology
|
2006
|
1.48
|
|
5
|
Inactivation of Src family kinases inhibits angiogenesis in vivo: implications for a mechanism involving organization of the actin cytoskeleton.
|
Exp Cell Res
|
2003
|
1.08
|
|
6
|
Inactivation of membrane tumor necrosis factor alpha by gingipains from Porphyromonas gingivalis.
|
Infect Immun
|
2005
|
1.01
|
|
7
|
Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells.
|
Eur J Biochem
|
2004
|
0.86
|
|
8
|
An ex vivo model for functional studies of myofibroblasts.
|
Lab Invest
|
2005
|
0.86
|
|
9
|
EGFR lung cancer mutants get specialized.
|
Proc Natl Acad Sci U S A
|
2013
|
0.82
|
|
10
|
Retraction Notice to: An ATP-Competitive Inhibitor Modulates the Allosteric Function of the HER3 Pseudokinase.
|
Cell Chem Biol
|
2017
|
0.75
|